Robert L. Cohen
15Patents
10h-index
27Co-inventors
72Inventor score
Filing activity: Dec 22, 1981 → Oct 30, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6573043B1 | Tissue analysis and kits therefor | Physics | 181 | Expired |
| US7674589B2 | Methods for tissue analysis | Physics | 61 | Active |
| US6905830B2 | Tissue analysis and kits therefor | Physics | 25 | Expired |
| US8742076B2 | Nemorubicin metabolite and analog reagents, antibody-drug conjugates and methods | Chemistry; Metallurgy | 25 | Active |
| US7919254B2 | Tissue analysis and kits therefor | Physics | 23 | Active |
| US7344840B2 | Tissue analysis and kits therefor | Physics | 23 | Expired |
| US7129051B2 | Tissue analysis and kits therefor | Physics | 21 | Expired |
| US7468252B2 | Methods for tissue analysis | Physics | 21 | Active |
| US8900589B2 | Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds | Chemistry; Metallurgy | 19 | Active |
| US4463453A | Acoustic intensity measurement apparatus and method including probe having ambient noise shield | Emerging Cross-Sectional Technologies | 14 | Expired |
| US6387657B1 | WISP polypeptides and nucleic acids encoding same | Chemistry; Metallurgy | 8 | Expired |
| US9695240B2 | Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds | Chemistry; Metallurgy | 8 | Active |
| US9492553B2 | Nemorubicin metabolite and analog reagents, antibody-drug conjugates and methods | Chemistry; Metallurgy | 8 | Active |
| US9145801B2 | Systems and methods for acoustic resonance mitigation | Performing Operations; Transporting | 2 | Active |
| US8350008B2 | WISP polypeptides and nucleic acids encoding same | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.